VitalityCardiology

EMPAREG: Jardiance reduces MI, CVA, death in patients with vascular disease [SGLT-2 inhibitor]

​

LEADER: Victoza reduces MI, CVA, death in patients with vascular disease [GLP-1 agonist]

​

​

​

​